These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study. Qureshi AI; Miley JT; Chaudhry SA; Semaan E; Rodriguez GJ; Suri MF; Adams HP J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1076-81. PubMed ID: 23099041 [TBL] [Abstract][Full Text] [Related]
33. Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator. Wei XE; Zhao YW; Lu J; Li MH; Li WB; Zhou YJ; Li YH Acta Radiol; 2015 Sep; 56(9):1119-26. PubMed ID: 25182802 [TBL] [Abstract][Full Text] [Related]
34. Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab. Berrouschot J; Stoll A; Hogh T; Eschenfelder CC Stroke; 2016 Jul; 47(7):1936-8. PubMed ID: 27301937 [TBL] [Abstract][Full Text] [Related]
35. Ischemic stroke and excellent recovery after administration of intravenous tissue plasminogen activator. Jain SV; Morton LD Pediatr Neurol; 2008 Feb; 38(2):126-9. PubMed ID: 18206794 [TBL] [Abstract][Full Text] [Related]
36. Intravenous thrombolysis in SLE-related stroke: a case report and literature review. Chen X; Xu G Neurol Sci; 2018 Jan; 39(1):155-159. PubMed ID: 29116545 [TBL] [Abstract][Full Text] [Related]